Navigation Links
Optimal Treatment Boosts Blacks' Lung Cancer Survival
Date:1/19/2009

Patients who received recommended care did better, regardless of race, study found

MONDAY, Jan. 19 (HealthDay News) -- Survival disparities between white and black patients with early-stage lung cancer disappear when black patients receive optimal therapy, according to a U.S. study that included nearly 18,000 patients.

Surgery to remove a portion of the lung (pulmonary resection) provides the best chance of a cure for patients with early-stage lung cancer.

"Black patients with early-stage lung cancer have lower five-year survival rates than white patients, and this difference in outcome has been attributed to lower rates of resection among black patients," wrote Dr. Farhood Farjah, of the University of Washington, Seattle, and colleagues. "Several potential factors underlying racial differences in the receipt of surgical therapy include differences in pulmonary function, access to care, refusal of surgery, beliefs about tumor spread on air exposure at the time of operation and the possibility of cure without surgery, distrust of the health care system and physicians, suboptimal patterns of patient and physician communication and health care system and provider biases."

Access to care is often considered the most important of the factors that affect racial disparities among lung cancer patients.

The study looked at nearly 18,000 patients (89 percent white and 6 percent black) who were diagnosed with lung cancer between 1992 and 2002 and recommended for pulmonary resection.

The researchers found that 69 percent of black patients had surgery, compared with 83 percent of white patients. Five-year survival rates were similar among both black and white patients who had surgery.

"Although these findings do not refute the likely roles of health care system and provider biases and patient characteristics as important causal factors underlying health disparities, the findings do suggest that other factors (i.e., distrust, perceptions and beliefs about lung cancer and its treatment and limited access to subspecialty care) may have a more dominant role in causing disparities than previously recognized," the study authors wrote.

"The implication of these findings is that interventions designed to narrow gaps in health care should target structured aspects of care, providers and patients and communities at risk for lung cancer and suboptimal care," the team added.

The researchers suggested that referral of all patients with potentially curable lung cancer for consideration of lung resection may help reduce racial disparities in survival.

The study was published in the January issue of the journal Archives of Surgery.

More information

The U.S. National Cancer Institute has more about lung cancer.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Jan. 19, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Optimal systemic and splanchnic hemodynamic state after living-donor liver transplantation
2. In largest U.S. Hep C trial, researchers determine weight-based dosing is key to optimal treatment
3. Join the Vitamin D Revolution: How to Get 30 Minutes of Daily Sunshine for Optimal Health
4. Optimal band imaging with endoscopy facilitates the diagnosis of depressed-type early gastric cancer
5. Do patients with inflammatory bowel disease receive optimal care?
6. Kronos Optimal Health Company Aims to Stop Diabetes Before It Starts
7. Navigenics(TM) Launches Health Compass Service, a Personal Genetic Assessment for Optimal Health
8. Optimal Readings Appoints Operations Veteran Rita Edwards as SVP Clinical Operations
9. Optimal Readings Selected to Present at CEDs 25th Annual Venture Conference
10. Medco, Healthways Launch Center for Health Action to Deliver Optimal Health(TM)
11. eHealth Initiative and the Center for Improving Medication Management to Present Report Detailing Both Impact of E-Prescriptions on U.S. Health Care System and Guidelines for Achieving Optimal Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Optimal Treatment Boosts Blacks' Lung Cancer Survival 
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Mediaplanet is ... Wound Care" campaign in USA Today, which will educate readers on how to take ... the campaign, a large focus is placed on melanoma. Dancing with the Stars professional, ...
(Date:5/26/2017)... , ... May 26, 2017 , ... ... of the CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface ... browser-based interface for diagnostic device operations. With this platform, initializing devices and importing ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on ... continue to be available at a discounted crowdfunding price on Indiegogo . , ... are, I also wanted to bring a fidget toy to the market that was ...
(Date:5/26/2017)... ... ... “When the Stars Lead Home”: a poignant story of loss, determination, and perseverance. “When ... avid reader who lives in the Pacific Northwest with her husband, daughter, two dogs, ... She couldn’t be more grateful. , Twelve-year old Tizzy could not believe how quickly ...
(Date:5/26/2017)... ... , ... Water damage to the flooring of several classrooms at The Fort ... with a number of critical issues to address before students could return to classes. ... little or no disruption to class schedules. Second, the project had to comply with ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... 10, 2017 Global Health Intelligence (GHI), ... America , published its 2017 ranking of the ... on extensive data analysis from GHI,s hospitals database for ... for the region. The GHI database covers 86% of the ... than 130 data points for each institution in key areas ...
(Date:5/10/2017)... 2017 CSSi, the global leader in patient ... industry, is proud to announce the launch of its ... features both enriched content and a customized layout that ... company,s already well-established position as the top global patient ... many months of hard work, we are delighted to ...
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
Breaking Medicine Technology: